Kaveri Seed Company is currently trading at Rs. 469.50, up by 3.95 points or 0.85% from its previous closing of Rs. 465.55 on the BSE.
The scrip opened at Rs. 466.25 and has touched a high and low of Rs. 471.60 and Rs. 464.50 respectively. So far 3512 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 2 has touched a 52 week high of Rs. 623.00 on 01-Feb-2019 and a 52 week low of Rs. 376.00 on 20-Feb-2019.
Last one week high and low of the scrip stood at Rs. 474.00 and Rs. 456.05 respectively. The current market cap of the company is Rs. 2939.29 crore.
The promoters holding in the company stood at 55.09%, while Institutions and Non-Institutions held 29.65% and 15.26% respectively.
Kaveri Seed Company has launched its state of the art Biotechnology laboratory at Pamulaparthy in Telangana. The initiative is part of the company’s strong focus on enhancing its R&D and innovation capabilities aimed at improving agricultural productivity and be optimally positioned to leverage future growth opportunities.
The laboratory named ‘Centre for Applied Genomics and Seed Technology’ will house the latest infrastructure and will focus on developing quality hybrids for all crops.
Kaveri Seed Company is an India-based company. The Company is an integrated provider of farm solutions focusing on hybrid seeds, micro-nutrients, such as soil enhancers and organic fungicides/pesticides, and vegetables/ herbs for the domestic and export markets.